WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY

Saved in:
Bibliographic Details
Main Authors: Aneesh Thomas George, Richard Lafayette, Sydney Tang, Serge Smeets, Carolina Aldworth, Raymond Przybysz, Emma Chatterton
Format: Article
Language:English
Published: Elsevier 2024-04-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924004054
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849468386935832576
author Aneesh Thomas George
Richard Lafayette
Sydney Tang
Serge Smeets
Carolina Aldworth
Raymond Przybysz
Emma Chatterton
author_facet Aneesh Thomas George
Richard Lafayette
Sydney Tang
Serge Smeets
Carolina Aldworth
Raymond Przybysz
Emma Chatterton
author_sort Aneesh Thomas George
collection DOAJ
format Article
id doaj-art-7ac9bc3dca5a4617a465e1fc54331682
institution Kabale University
issn 2468-0249
language English
publishDate 2024-04-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-7ac9bc3dca5a4617a465e1fc543316822025-08-20T03:25:53ZengElsevierKidney International Reports2468-02492024-04-0194S15510.1016/j.ekir.2024.02.316WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDYAneesh Thomas George0Richard Lafayette1Sydney Tang2Serge Smeets3Carolina Aldworth4Raymond Przybysz5Emma Chatterton6Hyderabad, Global Business Solutions, IndiaNephrology, Stanford University Medical Center, StanfordNephrology, The University of Hong Kong, Hong Kong SARMedical, Novartis Pharma AG, BaselMedical, Novartis Pharmaceuticals Corporation, East HanoverRWE and Innovative Evidence, Novartis Pharmaceuticals Corporation, East HanoverRare Diseases, Adelphi Real World, Bollingtonhttp://www.sciencedirect.com/science/article/pii/S2468024924004054
spellingShingle Aneesh Thomas George
Richard Lafayette
Sydney Tang
Serge Smeets
Carolina Aldworth
Raymond Przybysz
Emma Chatterton
WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY
Kidney International Reports
title WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY
title_full WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY
title_fullStr WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY
title_full_unstemmed WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY
title_short WCN24-1163 TREATMENT GOALS FROM THE PERSPECTIVE OF IMMUNOGLOBULIN A NEPHROPATHY PATIENTS - RESULTS FROM A REAL-WORLD STUDY
title_sort wcn24 1163 treatment goals from the perspective of immunoglobulin a nephropathy patients results from a real world study
url http://www.sciencedirect.com/science/article/pii/S2468024924004054
work_keys_str_mv AT aneeshthomasgeorge wcn241163treatmentgoalsfromtheperspectiveofimmunoglobulinanephropathypatientsresultsfromarealworldstudy
AT richardlafayette wcn241163treatmentgoalsfromtheperspectiveofimmunoglobulinanephropathypatientsresultsfromarealworldstudy
AT sydneytang wcn241163treatmentgoalsfromtheperspectiveofimmunoglobulinanephropathypatientsresultsfromarealworldstudy
AT sergesmeets wcn241163treatmentgoalsfromtheperspectiveofimmunoglobulinanephropathypatientsresultsfromarealworldstudy
AT carolinaaldworth wcn241163treatmentgoalsfromtheperspectiveofimmunoglobulinanephropathypatientsresultsfromarealworldstudy
AT raymondprzybysz wcn241163treatmentgoalsfromtheperspectiveofimmunoglobulinanephropathypatientsresultsfromarealworldstudy
AT emmachatterton wcn241163treatmentgoalsfromtheperspectiveofimmunoglobulinanephropathypatientsresultsfromarealworldstudy